Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea-Hypopnea Syndrome

Principles and Practice of Sleep Medicine

Volumn , Issue , 2005, Pages 1066-1080

  Grunstein, Ronald ^a,b,c  

^a University of Sydney   (Australia)

^b WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882858036     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160797-7/50096-3     Document Type: Chapter

References (83)

1. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981, 1:862-865.
2. Grunstein RR, Dodd MJ, Costas L, et al. Home nasal CPAP for sleep apnea: Acceptance of home therapy and its usefulness. Aust N Z J Med 1986, 16:635.
3. Grunstein RR Sleep-related breathing disorders: 5. nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Thorax 1995, 50:1106-1113.
4. Grunstein RR, Hedner J, Grote L Therapy of sleep apnea. Drugs 2001, 61:237-251.
5. Remmers JE, De Groot WJ, Sauerland EK, et al. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978, 44:931-938.
6. Strohl KP, Redline S Nasal CPAP therapy, upper air-way muscle activation and obstructive sleep apnea. Am Rev Respir Dis 1986, 134:555-558.
7. Schwab RJ, Pack AI, Gupta KB, et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med 1996, 154:1106-1116.
8. Issa FG, Sullivan CE Reversal of central sleep apnea using nasal CPAP. Chest 1986, 90:165-171.
9. Zozula R, Rosen R Compliance with continuous positive airway pressure therapy: Assessing and improving treatment outcomes. Curr Opin Pulm Med 2001, 7:391-398.
10. Fitzpatrick MF, Alloway CED, Wakeford TM, et al. Can patients with obstructive sleep apnea titrate their own continuous positive airway pressure?. Am J Respir Crit Care Med 2003, 167:716-722.
11. Montserrat JM, Ballester E, Olivi H, et al. Time-course of step-wise CPAP titration: Behavior of respiratory and neurological variables. Am J Respir Crit Care Med 1995, 152:1854-1859.
12. Hosselet JJ, Norman RG, Ayappa I, et al. Detection of flow limitation with a nasal cannula/pressure transducer system. Am J Respir Crit Care Med 1998, 157:1461-1467.
13. Meurice JC, Paquereau J, Denjean A, et al. Influence of correction of flow limitation on continuous positive airway pressure efficiency in sleep apnoea/hypopnoea syndrome. Eur Respir J 1998, 11:1121-1127.
14. Issa FG, Sullivan CE The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 1986, 63:10-17.
15. Condos R, Norman RG, Krishnasamy I, et al. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Respir Crit Care Med 1994, 150:475-480.
16. Pevernagie DA, Shepard JW Relations between sleep stage, posture and effective nasal CPAP levels in OSAHS. Sleep 1992, 15:162-167.
17. Marrone O, Insalaco G, Bonsignore MR, et al. Sleep structure correlates of continuous positive airway pressure variations during application of an autotitrating continuous positive airway pressure machine in patients with obstructive sleep apnea syndrome. Chest 2002, 121:759-767.
18. Jokic R, Klimaszewski A, Sridhar G, et al. Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea. Chest 1998, 114:1061-1069.
19. Willson G, Grunstein RR, Doyle J, et al. Domiciliary use of autoset nasal continuous positive airway pressure (nCPAP): Feasibility, efficacy and night to night variability. Sleep Res 1996, 25:210.
20. Miljeteigh H, Hoffstein V Continuous positive airway pressure for treatment of obstructive sleep apnea. Am Rev Respir Dis 1993, 147:1526-1530.
21. Berry RB, Desa MM, Light RW Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest 1991, 99:339-343.
22. Becker HF, Piper AJ, Flynn WE, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 1999, 159:112-118.
23. Sanders MH, Kern NB, Costantino JP, et al. Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial-night trial. Am Rev Respir Dis 1993, 147:1169-1174.
24. McArdle N, Grove A, Devereux G, et al. Split-night versus full-night studies for sleep apnoea/hypopnoea syndrome. Eur Respir J 2000, 15:670-675.
25. Rosenthal L, Nykamp K, Guido P, et al. Daytime CPAP titration: A viable alternative for patients with severe obstructive sleep apnea. Chest 1998, 114:1056-1060.
26. Littner M, Hirshkowitz M, Davila D, et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep 2002, 25:143-147.
27. Krieger J, Sforza E, Petiau C, et al. Simplified diagnostic procedure for obstructive sleep apnoea syndrome: Lower subsequent compliance with CPAP. Eur Respir J 1998, 12:776-779.
28. White DP, Gibb TJ Evaluation of the Healthdyne NightWatch system to titrate CPAP in the home. Sleep 1998, 21:198-204.
29. Juhasz J, Schillen J, Urbigkeit A, et al. Unattended continuous positive airway pressure titration: Clinical relevance and cardiorespiratory hazards of the method. Am J Respir Crit Care Med 1996, 154:359-365.
30. Hoffstein V, Mateika S Predicting nasal continuous positive airway pressure. Am J Respir Crit Care Med 1994, 150:486-488.
31. Engleman HM, Asgari-Jirhandeh N, McLeod AL, et al. Self-reported use of CPAP and benefits of CPAP therapy: A patient survey. Chest 1996, 109:10470-11476.
32. Strollo PJ, Sanders MH, Atwood CW Positive pressure therapy. Clin Chest Med 1998, 19:55-68.
33. Pepin JL, Leger P, Veale D, et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: Study of 193 patients in two French sleep centers. Chest 1995, 107:375-381.
34. Richards GN, Cistulli PA, Unger RG, et al. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996, 154:182-186.
35. Martins de Araujo MT, Vieira SB, Vasquez EC, et al. Heated humidification or face mask to prevent upper airway dryness during continuous positive airway pressure therapy. Chest 2000, 117:142-147.
36. Friedman M, Tanyeri H, Lim JW, et al. Effect of improved nasal breathing on obstructive sleep apnea. Otolaryngol Head Neck Surg 2000, 122:71-74.
37. Beecroft J, Zanon S, Lukic D, Hanly P Oral continuous positive airway pressure for sleep apnea: Effectiveness, patient preference, and adherence. Chest 2003, 124:2200-2208.
38. Stauffer JL, Fayter NA, McClure BJ Conjunctivitis from nasal CPAP apparatus. Chest 1984, 86:802.
39. Bucca C, Carossa S, Pivetti S, et al. Edentulism and worsening of obstructive sleep apnoea. Lancet 1999, 353:121-122.
40. Pressman MR, Peterson DD, Meyer TJ, et al. Ramp abuse: A novel form of patient noncompliance to administration of nasal continuous positive airway pressure for treatment of obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151:1632-1634.
41. Reeves-Hoche MK, Hudgel DW, Meck R, et al. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151:443-449.
42. Gay PC, Herold DL, Olson EJ A randomized, double-blind clinical trial comparing continuous positive airway pressure with a novel bilevel pressure system for treatment of obstructive sleep apnea syndrome. Sleep 2003, 26:864-869.
43. Lojander J, Maasilta P, Partinen M, et al. Nasal-CPAP, surgery, and conservative management for treatment of obstructive sleep apnea syndrome: A randomized study. Chest 1996, 110:114-119.
44. Spilker B Guide to Clinical Trials 1991, Raven Press, New York.
45. Rand CS, Wise RA, Nides N, et al. Medication adherence in a clinical trial. Am Rev Respir Dis 1992, 146:1559-1564.
46. Haynes RB, Taylor DW, Sackett DL Compliance in Health 1979, Johns Hopkins University Press, Baltimore.
47. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993, 147:887-895.
48. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994, 343:572-575.
49. Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993, 147:1162-1168.
50. Grunstein RR, Handelsman DJ, Lawrence S, et al. Neuroendocrine dysfunction in sleep apnea: reversal by nasal continuous positive airways pressure. J Clin Endocrinol Metab 1989, 68:352-358.
51. Hers V, Liistro G, Dury M, et al. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Respir J 1997, 10:973-976.
52. Van Dongen HP, Maislin G, Dinges DF Dealing with interindividual differences in the temporal dynamics of fatigue and performance: Importance and techniques. Aviat Space Environ Med 2004, 75(Suppl 3):A147-A154.
53. Rauscher H, Popp W, Wanke T, et al. Acceptance of CPAP therapy for sleep apnea. Chest 1991, 100:1019-1023.
54. Meurice JC, Dore P, Paquereau J, et al. Predictive factors of long term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994, 105:429-433.
55. Grunstein R Investigation and treatment of sleep apnea in Australia 1991-95. Am J Respir Crit Care Med 1997, 155:A133.
56. Weaver TE, Kribbs NB, Pack AI, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997, 20:278-283.
57. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:1108-1114.
58. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: A randomized, controlled trial. Ann Intern Med 2001, 134:1015-1023.
59. Patel SR, White DP, Malhotra A, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: Results of a meta-analysis. Arch Intern Med 2003, 163:565-571.
60. Bennett LS, Langford BA, Stradling JR, et al. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea. Am J Respir Crit Care Med 1998, 158:778-786.
61. Drake CL, Day R, Hudgel D, et al. Sleep during titration predicts continuous positive airway pressure compliance. Sleep 2003, 26:308-311.
62. Hoy CJ, Vennelle M, Kingshott RN, et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?. Am J Respir Crit Care Med 1999, 159:1096-1100.
63. Grote L, Hedner J, Grunstein R, Kraiczi H Therapy with nCPAP: Incomplete elimination of sleep related breathing disorder. Eur Respir J 2000, 16:921-927.
64. Stepnowsky CJ, Moore PJ Nasal CPAP treatment for obstructive sleep apnea: Developing a new perspective on dosing strategies and compliance. J Psychosom Res 2003, 54:599-605.
65. White J, Cates C, Wright J Continuous positive airways pressure for obstructive sleep apnoea. Cochrane Database Syst Rev 2002, CD001106(2).
66. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised parallel trial. Lancet 2002, 359:204-210.
67. Barnes M, Houston D, Worsnop CJ, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:773-780.
68. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: Types and their prevalences, consequences, and presentations. Circulation 1998, 97:2154-2159.
69. Bradley TD, Floras JS Sleep apnea and heart failure: Part II. Central sleep apnea. Circulation 2003, 107:1822-1826.
70. Bradley TD, Floras JS Sleep apnea and heart failure: Part I. Obstructive sleep apnea. Circulation 2003, 107:1671-1678.
71. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348:1233-1241.
72. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361-366.
73. Topfer V, El-Sebai M, Wessendorf TE, et al. Adaptive servoventilation: Effect on Cheyne-Stokes respiration and on quality of life. Pneumologie 2004, 58:28-32.
74. Bradley TD, Logan AG, Floras JS, CANPAP Investigators Rationale and design of the Canadian Continuous Positive Airway Pressure Trial for Congestive Heart Failure Patients with Central Sleep Apnea-CANPAP. Can J Cardiol 2001, 17:677-684.
75. Berthon-Jones M Feasibility of a self-setting CPAP machine. Sleep 1993, 16:S120-S121.
76. Roux FJ, Hilbert J Continuous positive airway pressure: new generations. Clin Chest Med 2003, 24:315-342.
77. Ayas NT, Patel SR, Malhotra A, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: Results of a meta-analysis. Sleep 2004, 27:249-253.
78. Kuna ST Can continuous positive airway pressure be self-titrated?. Am J Respir Crit Care Med 2003, 167:674-675.
79. Engleman HM, McDonald JP, Graham D, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: Continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002, 166:855-859.
80. Lafond C, Sériès F Influence of nasal obstruction on auto-CPAP behaviour in the treatment of obstructive sleep apnea/hypopnea syndrome. Thorax 1998, 53:780-783.
81. Pack AI, Black JE, Schwartz JR, Matheson JK Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001, 164:1675-1681.
82. Woodson BT, Steward DL, Weaver EM, et al. A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg 2003, 128:848-861.
83. Yamashiro Y, Kryger MH CPAP titration for sleep apnea using a split-night protocol. Chest 1995, 107:62-66.